Egetis Therapeutics AB(SE:EGTX)
kr 11.20+0.08 (+0.72%)
SE:EGTX
Egetis Therapeutics AB financials statements
kr 11.20
At close:+0.08 (+0.72%)
Want to see SE:EGTX full AI Analyst Report?
Egetis Therapeutics AB (EGTX) Income Statement
1 Followers
Egetis Therapeutics AB Income Statement
Last quarter (Q3 2026), Egetis Therapeutics AB's total revenue was kr21.50M, an increase of 23.56% from the same quarter last year. In Q3, Egetis Therapeutics AB's net income was kr-147.00M. See Egetis Therapeutics AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| kr 62.40M | kr 46.10M | kr 57.60M | kr 22.50M | kr 38.24M | |
| kr 12.40M | kr 34.50M | kr -146.90M | kr -120.10M | kr -58.28M | |
| kr 359.30M | kr 363.90M | kr 177.90M | kr 54.70M | kr 46.80M | |
| Depreciation and Amortization | kr 3.70M | kr 0.00 | kr 3.60M | kr 2.70M | kr 2.46M |
| kr -343.20M | kr -317.30M | kr -319.10M | kr -191.00M | kr -101.90M | |
| kr -346.90M | kr -329.40M | kr -324.80M | kr -198.10M | kr -105.68M | |
| kr 4.80M | kr -13.80M | kr -2.00M | kr 4.30M | kr 1.18M | |
| kr -342.10M | kr -343.20M | kr -326.80M | kr -193.80M | kr -104.54M | |
| kr -342.50M | kr -343.60M | kr -326.90M | kr -189.50M | kr -104.73M | |
| Per Share Metrics | |||||
| Basic EPS | kr -0.93 | kr -1.12 | kr -1.27 | kr -0.98 | kr -0.58 |
| Diluted EPS | kr -0.93 | kr -1.12 | kr -1.26 | kr -0.98 | kr -0.58 |
| Weighted Average Shares Outstanding | 368.19M | 306.54M | 256.75M | 194.24M | 179.91M |
| Weighted Average Shares Outstanding (Diluted) | 368.19M | 306.54M | 260.01M | 194.24M | 179.91M |
Currency in SEK
